BRD2 and neoplasm: Promoter methylation of the PITX2ab variant positively correlated with PITX2c (Spearman’s ρ = 0.333; p = 0.003; n = 78) in tumor samples as well as in NAT specimens (Spearman’s ρ = 0.345, p = 0.014, n = 50).